BCL2 and telomere syndrome: We hypothesize that pre-operative RT-induced senescence in STS can be exploited to modify cell fate from senescence towards a rapid cell death through the administration of a Bcl2 family anti-apoptotic proteins inhibitor in the time window between RT and surgery.